Trial
NCT05292950
Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Arrowhead Pharmaceuticals
Collaborators
—
Condition
Asthma
Intervention
ARO-MUC5AC
Why stopped
Sponsor business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-05